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ABSTRACT 
 The stereoselective synthesis of all carbon quaternary stereocenters is an important problem in 
synthetic chemistry due to their common occurrence in bioactive compounds.  The zoanthamine class of 
marine natural products highlights the challenge in constructing such stereocenters.  After a summary of the 
isolation, structure determination, and biological activities of the zoanthamine natural products, published 
approaches toward their chemical synthesis are reviewed.   
 Synthetic strategies toward the carbocyclic portion of zoanthenol focus on the synthesis of the 
three challenging quaternary stereocenters located on the central C ring.  An unusual acid-mediated SN' 
cyclization of a nucleophilic arene with an allylic alcohol forms the B ring and diastereoselectively 
constructs the benzylic C(12) quaternary stereocenter.  However, difficulties with late-stage installation of 
the remaining C(9) quaternary stereocenter compelled the use of C ring synthons containing the vicinal 
C(9) and C(22) stereocenters installed at an early stage in the synthesis.  Desymmetrization of a meso-
anhydride containing vicinal quaternary stereocenters accomplishes this goal in an enantioselective fashion.  
Several C ring synthons bearing the vicinal quaternary stereocenters are elaborated with A ring fragments, 
and several methods for the formation of the C(11)-C(12) bond in these systems are explored.  Ultimately, 
a radical conjugate addition strategy provides the carbocyclic core of zoanthenol with the correct relative 
configuration of all three quaternary stereocenters.   
 These efforts toward the synthesis of zoanthenol highlight the difficulty in generating 
enantioenriched ?-quaternary cycloalkanones derived from ketones with multiple acidic ?-hydrogens.  The 
first direct catalytic enantioselective access to such products is achieved by the application of chiral 
bidentate phosphinooxazoline (PHOX) ligands to Tsuji’s non-enantioselective allylation reactions.  Cyclic 
allyl enol carbonates, silyl enol ethers, and allyl ?-ketoesters all provide uniformly excellent yields and 
high enantioselectivity in the reaction.  The limitations on the substrate scope of the reaction are discussed.  
Preliminary studies into the mechanism of these allylation reactions with prochiral enolate fragments 
suggest that they occur by a different mechanism than the outer-sphere nucleophilic attack commonly 
proposed in the alkylation of prochiral allyl fragments. 
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DMP Dess-Martin periodinane 
DMPU N,N'-dimethyl propylene urea 
DMS dimethylsulfide 
DMSO dimethylsulfoxide 
DNA deoxyribonucleic acid 
DPPB 1,4-bis(diphenylphosphino)butane 
DPPE 1,2-bis(diphenylphosphino)ethane 
dr diastereomeric ratio  
ee enantiomeric excess 
E entgegen olefin geometry 
EI electrospray ionization 
equiv equivalent(s) 
Et ethyl 
EtOAc ethyl acetate 
FAB fast atom bombardment 
g gram 
GC gas chromatography 







HMDS hexamethyldisilazide or hexamethyldisilizane 
HMPA hexamethylphosphoramide 
HPLC high performance liquid chromatography 
HRMS high resolution mass spectroscopy 
Hz hertz 
?n eta; n = number of atoms coordinated to metal 
IC50 concentration required for 50% growth inhibition 
imid. imidazole 
IR infrared spectroscopy 
J coupling constant 
kn rate constant, n refers to various reactions, negative 
n indicates reverse reaction 
 
kcal kilocalories 
KHMDS potassium hexamethyldisilazide 
L liter 
LAH lithium aluminum hydride 
LDA lithium diisopropylamide 
LD50 Lethal Dosage to kill 50% of test population 
LiHMDS lithium hexamethyldisilazide 
 xxxix
m meta 
m multiplet or milli 
μ micro  
M mega, metal, or molar 
m/z mass to charge ratio 





MEK methyl ethyl ketone 
MH-60 mouse myelohybridoma cells 
MIC minimal inhibitory concetration 
min minute(s) 
mol mole(s) 





mp melting point 
Ms methanesulfonyl 
MS molecular sieves 
MTPA ?-methoxy-?-(trifluoromethyl)phenylacetic acid  




NMR nuclear magnetic resonance 




PCC pyridinium chlorochromate 
PDC pyridinium dichromate 
PG prostaglandin 
Ph phenyl 





PMA phorbol myristate acetate 
PMB p-methoxybenzyl 
PMBM p-methoxybenzyloxymethyl 
p.o. administered orally 
ppm parts per million 




psi pounds per square inch 





R alkyl group 
R rectus (configurational) 
Red-Al sodium bis(2-methoxyethoxy)aluminum hydride 
Rf retention factor 
RNA ribonucleic acid 
s singlet 
S sinister (configurational) 




TBAF tetrabutylammonium fluoride 








TFA trifluoroacetic acid 
THF tetrahydrofuran 
TIPS triisopropylsilyl 
TLC thin-layer chromatography 
TMEDA tetramethylethylenediamine 
TMS trimethylsilyl 
TOF turnover frequency 
TON turnover number 
TPAP tetrapropylammonium perruthenate 
TROC trichloroethoxycarbonyl 
Ts p-toluenesulfonyl or p-toluenesulfonic 
UV ultraviolet 
Vis visual wavelength 
v/v volume per volume 
w/v weight per volume 
X halide or trifluoromethanesulfonate 
Z     zusammen olefin geometry 
